The real-time assessment is made possible by integrating Aiosyn’s pathology platform into Pramana’s AI edge compute ...

Learn about the company's ambitious plans for its Arlington facility in this story. A medical diagnostic equipment ...

IDEXX Laboratories' oncology panel and share buybacks boost outlook. Read why IDXX stock is upgraded to buy with growth ...

Elon Musk suggested that a movement to pardon former police officer Derek Chauvin was 'something to think about' in a post to ...

<img src='/mnt/data/histo_images/slide_1_0.png'>;Unlabeled slide - Requires manual classification <img src='/mnt/data/histo_images/slide_1_1.png'>;Unlabeled slide ...

Cancer recurrence prediction is inherently complex due to the interplay of genetic, environmental, and treatment-related factors. Traditional statistical models such as the Cox proportional hazards ...

Orion Corporation extends collaboration with Aiforia Technologies for preclinical study evaluations: Helsinki, Finland Friday, March 7, 2025, 12:00 Hrs [IST] Orion Corporation, a ...

Altimmune's pemvidutide shows promise in treating MASH and obesity, with upcoming Phase 2b results poised to shape its market impact. Read more on ALT stock here.

Orion and Aiforia extend collaboration to preclinical study evaluations ...